{
     "PMID": "28693823",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20171127",
     "LR": "20171128",
     "IS": "1433-2981 (Electronic) 0936-6555 (Linking)",
     "VI": "29",
     "IP": "11",
     "DP": "2017 Nov",
     "TI": "Feasibility of Hippocampal Avoidance Radiotherapy for Glioblastoma.",
     "PG": "748-752",
     "LID": "S0936-6555(17)30285-6 [pii] 10.1016/j.clon.2017.06.010 [doi]",
     "AB": "With improvements in survival for good performance status patients and in specific molecular subtypes of glioblastoma, some patients will survive to develop significant neurocognitive dysfunction. This retrospective planning study quantified hippocampal radiation doses in patients with glioblastoma receiving radical chemo-radiotherapy and compared this with the radiation doses that showed clinical correlation with neurocognitive dysfunction, and evaluated the potential for clinically meaningful hippocampal dose reduction using helical TomoTherapy((R)).",
     "CI": [
          "Copyright (c) 2017 The Royal College of Radiologists. Published by Elsevier Ltd.",
          "All rights reserved."
     ],
     "FAU": [
          "Thippu Jayaprakash, K",
          "Wildschut, K",
          "Jena, R"
     ],
     "AU": [
          "Thippu Jayaprakash K",
          "Wildschut K",
          "Jena R"
     ],
     "AD": "Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Electronic address: kthippujayaprakash@doctors.org.uk. Department of Radiotherapy Physics, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170708",
     "PL": "England",
     "TA": "Clin Oncol (R Coll Radiol)",
     "JT": "Clinical oncology (Royal College of Radiologists (Great Britain))",
     "JID": "9002902",
     "SB": "IM",
     "MH": [
          "Female",
          "Glioblastoma/mortality/*radiotherapy",
          "Hippocampus/*radiation effects",
          "Humans",
          "Male",
          "Radiotherapy Dosage",
          "Radiotherapy Planning, Computer-Assisted/*methods"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Glioblastoma",
          "hippocampal avoidance radiotherapy",
          "neurocognitive dysfunction"
     ],
     "EDAT": "2017/07/12 06:00",
     "MHDA": "2017/11/29 06:00",
     "CRDT": [
          "2017/07/12 06:00"
     ],
     "PHST": [
          "2016/10/18 00:00 [received]",
          "2017/05/24 00:00 [revised]",
          "2017/05/30 00:00 [accepted]",
          "2017/07/12 06:00 [pubmed]",
          "2017/11/29 06:00 [medline]",
          "2017/07/12 06:00 [entrez]"
     ],
     "AID": [
          "S0936-6555(17)30285-6 [pii]",
          "10.1016/j.clon.2017.06.010 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Clin Oncol (R Coll Radiol). 2017 Nov;29(11):748-752. doi: 10.1016/j.clon.2017.06.010. Epub 2017 Jul 8.",
     "term": "hippocampus"
}